Riskpilot← Back to searchSign inGet full accessLEGENE I YTRE AS
ASActiveOrg 922106851Sagstuveien 1, 1914 Ytre EnebakkGeneral medical practice activities · NACE 8621Est. 20195 employees
Revenue 2024
NOK 3M
+8% vs 2023
EBITDA margin
14.0%
-4% vs 2023
Equity ratio
1.0%
Financial strength
Net profit 2024
NOK -6
-100% vs 2023
| Revenue | NOK 3M | +8% |
| EBITDA | NOK 426K | -4% |
| Net profit | NOK -6 | -100% |
| Total assets | NOK 2,3M | -17% |
| Equity | NOK 24K | +0% |
| Employees | 5 | — |
Legal name
LEGENE I YTRE AS
Org number
922106851
Legal form
Aksjeselskap
NACE code
8621 · General medical practice activities
Founded
24. januar 2019
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Levere legetjenester.
Address
Sagstuveien 1, 1914 Ytre Enebakk
Phone
+4764929222
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 225 | 2 478 | 2 625 | 2 822 | 3 044 |
| Staff expenses | −731 | −728 | −822 | −933 | −1 119 |
| EBITDA | 403 | 386 | 387 | 444 | 426 |
| Depreciation & amort. | −321 | −323 | −315 | −336 | −318 |
| EBIT | 82 | 63 | 72 | 109 | 108 |
| Net financials | −82 | −63 | −72 | −104 | −108 |
| Profit before tax | 0 | 0 | 0 | 5 | 0 |
| Tax | −0 | 0 | 5 | −1 | 0 |
| Net profit | 0 | −0 | −5 | 6 | −0 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 2 654 | 2 569 | 2 718 | 2 791 | 2 314 |
| Equity | 23 | 23 | 19 | 24 | 24 |
| Long-term debt | 2 251 | 2 034 | 1 817 | 1 600 | 1 383 |
| Short-term debt | 380 | 512 | 882 | 1 167 | 907 |
| Total debt | 2 631 | 2 546 | 2 699 | 2 767 | 2 290 |
EBITDA margin
14.0%
This company
15.8%
Market median
-11% vs market
20202024
Equity ratio
1.0%
This company
38.2%
Market median
-97% vs market
20202024
Return on equity
-0.0%
This company
18.4%
Market median
-100% vs market
20202024
Net profit margin
-0.0%
This company
8.1%
Market median
-100% vs market
20202024
Asset turnover
1.32×
This company
1.12×
Market median
+18% vs market
20202024
Debt / equity
94.57×
This company
0.62×
Market median
-15153% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LE Chief Executive Officer | Chief Executive Officer | 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2025 | |
| Board of Directors | 2025 | |
| Board of Directors | 2021 | |
| Former (2) | ||
| Chairman | 2021 – 2025 | |
| Chairman | 2020 – 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2023 | |
| Company | 25% | 25% | 2024 | |
| Company | 25% | 25% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ragna Engstad As
LEGENE I YTRE AS Board members of LEGENE I YTRE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lars Erik Fikke | Chief Executive Officer | 0 companies |
| Trine Otterstrøm | Chairman | 0 companies |
| Geir Erik Bye | Chairman | 0 companies |
| Tora Torgersen Engstad | Board of Directors | 0 companies |
| Ragna Torgersen Engstad | Board of Directors | 0 companies |
| Hege Breivik | Chairman | 0 companies |